Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lagerwaard FJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 26
Tytuł:
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study.
Autorzy:
Hurkmans CW
Cuijpers JP
Lagerwaard FJ
Widder J
van der Heide UA
Schuring D
Senan S
Hurkmans, Coen W
Cuijpers, Johan P
Lagerwaard, Frank J
Widder, Joachim
van der Heide, Uulke A
Schuring, Danny
Senan, Suresh
Pokaż więcej
Źródło:
Radiation Oncology; 2009, Vol. 4, p1-1, 1p
Czasopismo naukowe
Szczegóły
Tytuł:
Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.
Autorzy:
Doppenberg D; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Besselink MG; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Intven MPW; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Kazemier G; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands.
Meijerink M; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Intervention Radiology, Amsterdam, The Netherlands.
Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Nuyttens JJME; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Os R; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.
van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
van Tienhoven G; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Verkooijen HM; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Versteijne E; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Wilmink JW; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands.
Lagerwaard FJ; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Bruynzeel AME; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands. .; Cancer Center Amsterdam, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors:
Dutch Pancreatic Cancer Group
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 20; Vol. 23 (1), pp. 70. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.
Autorzy:
Doppenberg D; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Besselink MG; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Intven MPW; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Koerkamp BG; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Kazemier G; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands.
Meijerink M; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Intervention Radiology, Amsterdam, The Netherlands.
Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Nuyttens JJME; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Os R; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.
van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
van Tienhoven G; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Verkooijen HM; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Versteijne E; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Wilmink JW; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands.
Lagerwaard FJ; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Bruynzeel AME; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands. .; Cancer Center Amsterdam, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors:
Dutch Pancreatic Cancer Group
Źródło:
BMC cancer [BMC Cancer] 2022 Dec 29; Vol. 22 (1), pp. 1363. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Adenocarcinoma*/etiology
Pancreatic Neoplasms*/radiotherapy
Pancreatic Neoplasms*/etiology
Radiosurgery*
Humans ; Pituitary Adenylate Cyclase-Activating Polypeptide ; Prospective Studies ; Quality of Life ; Pancreatic Neoplasms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer.
Autorzy:
Tetar SU; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Bohoudi O; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Senan S; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Palacios MA; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Oei SS; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Wel AMV; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Slotman BJ; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Moorselaar RJAV; Department of Urology, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Lagerwaard FJ; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Bruynzeel AME; Department of Radiation Oncology, Amsterdam University Medical Centers, 1081 HZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Sep 25; Vol. 12 (10). Date of Electronic Publication: 2020 Sep 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
MR-guidance in clinical reality: current treatment challenges and future perspectives.
Autorzy:
Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany. .
Alongi F; Department of Radiation Oncology, IRCSS Sacro Cuore don Calabria Hospital, Negrar-Verona, Italy.; University of Brescia, Brescia, Italy.
Andratschke N; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zürich, Switzerland.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany.
Boldrini L; Istituto di Radiologia, Università Cattolica del Sacro Cuore, Rome, Italy.; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, UOC di Radioterapia Oncologica, Rome, Italy.
Cellini F; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, UOC di Radioterapia Oncologica, Rome, Italy.
Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zürich, Switzerland.
Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lagerwaard FJ; Department of Radiation Oncology, VU medical center, Amsterdam, The Netherlands.
Mazzola R; Department of Radiation Oncology, IRCSS Sacro Cuore don Calabria Hospital, Negrar-Verona, Italy.; University of Brescia, Brescia, Italy.
Palacios MA; Department of Radiation Oncology, VU medical center, Amsterdam, The Netherlands.
Philippens MEP; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Raaijmakers CPJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Terhaard CHJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Valentini V; Istituto di Radiologia, Università Cattolica del Sacro Cuore, Rome, Italy.; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, UOC di Radioterapia Oncologica, Rome, Italy.
Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2019 Jun 03; Vol. 14 (1), pp. 92. Date of Electronic Publication: 2019 Jun 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Magnetic Resonance Imaging*
Radiotherapy, Image-Guided*/trends
Neoplasms/*radiotherapy
Humans ; Neoplasms/diagnostic imaging ; Organs at Risk/diagnostic imaging ; Organs at Risk/radiation effects ; Precision Medicine ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy, Intensity-Modulated ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov.
Autorzy:
Cihoric N; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland. .
Tsikkinis A; Department of Genitourinary Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Minniti G; Unit of Radiation Oncology, Sant' Andrea Hospital, University Sapienza, and IRCCS Neuromed, Pozzilli (IS), Italy.
Lagerwaard FJ; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Herrlinger U; Department of Neurology, Division of Clinical Neurooncology, University of Bonn Medical Center, Bonn, Germany.
Mathier E; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Soldatovic I; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Jeremic B; Institute of Lung Diseases, Sremska Kamenica, Serbia and BioIRC Center for Biomedical Research, Kragujevac, Serbia.
Ghadjar P; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Elicin O; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Lössl K; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Aebersold DM; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Belka C; Department of Radiation Oncology, LMU Munich, München, Germany.; German Cancer Consortium (DKTK) & German Cancer Research Center (DKFZ), Heidelberg, Germany.
Herrmann E; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Niyazi M; Department of Radiation Oncology, LMU Munich, München, Germany.; German Cancer Consortium (DKTK) & German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2017 Jan 03; Vol. 12 (1), pp. 1. Date of Electronic Publication: 2017 Jan 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic/*methods
Glioblastoma/*therapy
Humans ; Research Design
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
Autorzy:
Verstegen NE; Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, Postbox 7057, 1007 MB, Amsterdam, The Netherlands.
Maat AP; Department of Cardiothoracic Surgery, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
Lagerwaard FJ; Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, Postbox 7057, 1007 MB, Amsterdam, The Netherlands. FJ.Lagerwaard@vumc.nl.
Paul MA; Department of Cardiothoracic Surgery, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Versteegh MI; Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Joosten JJ; Department of Surgery, Westfriesgasthuis Hoorn, Hoorn, The Netherlands.
Lastdrager W; Department of Surgery, Gelre Hospital Apeldoorn, Apeldoorn, The Netherlands.
Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Slotman BJ; Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, Postbox 7057, 1007 MB, Amsterdam, The Netherlands.
Nuyttens JJ; Department of Radiation Oncology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
Senan S; Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, Postbox 7057, 1007 MB, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2016 Oct 03; Vol. 11 (1), pp. 131. Date of Electronic Publication: 2016 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*
Salvage Therapy*
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Aged ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Combined Modality Therapy ; Female ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A critical review of recent developments in radiotherapy for non-small cell lung cancer.
Autorzy:
Baker S; Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, Canada, T6G 1Z2.
Dahele M; Department of Radiation Oncology, VU University Medical Center, De Boelelaan 1117, Postbox 7057, 1007 MD, Amsterdam, The Netherlands.
Lagerwaard FJ; Department of Radiation Oncology, VU University Medical Center, De Boelelaan 1117, Postbox 7057, 1007 MD, Amsterdam, The Netherlands.
Senan S; Department of Radiation Oncology, VU University Medical Center, De Boelelaan 1117, Postbox 7057, 1007 MD, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2016 Sep 06; Vol. 11 (1), pp. 115. Date of Electronic Publication: 2016 Sep 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Lung Neoplasms/*radiotherapy
Radiation Oncology/*methods
Radiotherapy/*methods
Radiotherapy, Intensity-Modulated/*methods
Carcinoma, Non-Small-Cell Lung/pathology ; Humans ; Lung Neoplasms/pathology ; Neoplasm Metastasis ; Neoplasm Staging/methods ; Proton Therapy/methods ; Radiation Oncology/trends ; Radiosurgery/methods ; Radiotherapy Planning, Computer-Assisted ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 26

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies